Cross-sectional evaluation of socioeconomic and clinical factors and the impact of fibromyalgia on the quality of life of patients during the COVID-19 pandemic
Keywords:
Fibromyalgia, Quality of life, Complementary therapies, Cross-sectional studies, PainAbstract
BACKGROUND: The fibromyalgia impact questionnaire (FIQ) relates to the functional capacity, professional situation, psychological disorders, and physical symptoms, and can identify the factors that determine the impact of the syndrome and characteristics of its carriers; the higher the score, the greater the impact of fibromyalgia on the quality of life. OBJECTIVE: To evaluate the impact of fibromyalgia on the quality of life of individuals with fibromyalgia, who were categorized according to the FIQ during the coronavirus disease pandemic. DESIGN AND SETTING: A cross-sectional study was conducted at an institution of higher education in Taquara, RS, Brazil. METHODS: A quantitative study was carried out, with the application of a sociodemographic and clinical questionnaire, and the FIQ in 163 Brazilian individuals with a medical diagnosis of fibromyalgia. Data were collected using SurveyMonkey software. RESULTS: Of the female carriers, 98.2% were living in urban areas, working, and under pharmacological and complementary treatment. The FIQ results showed that seven of the 10 items had the maximum score. The items “physical function” and “feel good” had intermediate scores, and the item “missed work” had a low score. The average total score was 79.9 points, indicating that fibromyalgia had a severe impact on the participants’ lives. A severe impact of fibromyalgia was observed in 61.3% of the participants, a moderate impact in 30.7%, and a low impact in 8%. CONCLUSION: The survey findings suggest a severe impact in the majority of the Brazilian fibromyalgic population.
Downloads
References
Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D. Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. Int J Mol Sci. 2021;22(8):3891. PMID: 33918736; https://doi.org/10.3390/ijms22083891.
Cabo-Meseguer A, Cerdá-Olmedo G, Trillo-Mata JL. Fibromyalgia: Prevalence, epidemiologic profiles and economic costs. Med Clin (Barc). 2017;149(10):441-8. PMID: 28734619; https://doi.org/10.1016/j.medclin.2017.06.008.
Marques AP, Santo ASDE, Berssaneti AA, Matsutani LA, Yuan SLK. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol Engl Ed. 2017;57(4):356-63. PMID: 28743363; https://doi.org/10.1016/j. rbre.2017.01.005.
Srinivasan S, Maloney E, Wright B, et al. The problematic nature of fibromyalgia diagnosis in the community. ACR Open Rheumatol. 2019;1(1):43-51. PMID: 31777779; https://doi.org/10.1002/acr2.1006.
Font Gayà T, Bordoy Ferrer C, Juan Mas A, et al. Prevalence of fibromyalgia and associated factors in Spain. Clin Exp Rheumatol. 2020;38 Suppl 123(1):47-52. PMID: 31928589.
Souza JB, Bourgault P, Charest J, Marchand S. Eficácia da escola interrelacional e interdisciplinar de fibromialgia: estudo randomizado controlado em longo prazo. BrJP. 2020;3(2):105-12. https://doi.org/10.5935/2595-0118.20200019.
Gittins R, Howard M, Ghodke A, Ives TJ, Chelminski P. The Accuracy of a Fibromyalgia Diagnosis in General Practice. Pain Med. 2018;19(3):491-8. PMID: 29016895; https://doi.org/10.1093/pm/pnx155.
Hayashi K, Miki K, Hayashi N, Hashimoto R, Yukioka M. Weather sensitivity associated with quality of life in patients with fibromyalgia. BMC Rheumatol. 2021;5(1):14. PMID: 33966632; https://doi.org/10.1186/s41927-021-00185-4.
Zetterman T, Markkula R, Partanen JV, et al. Muscle activity and acute stress in fibromyalgia. BMC MusculoskeletDisord. 2021;22(1):183. PMID: 33583408; https://doi.org/10.1186/s12891-021-04013-1.
Torales J, O’Higgins M, Castaldelli-Maia JM, Ventriglio A. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry. 2020;66(4):317-20. PMID: 32233719; https://doi.org/10.1177/0020764020915212.
Holmes EA, O’Connor RC, Perry VH, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7(6):547-60.PMID: 32304649; https://doi.org/10.1016/s2215-0366(20)30168-1.
Restubog SLD, Ocampo ACG, Wang L. Taking control amidst the chaos: Emotion regulation during the COVID-19 pandemic. J Vocat Behav. 2020;119:103440. PMID: 32390659; https://doi.org/10.1016/j.jvb.2020.103440.
Brandt R, Fonseca ABP, Oliveira LGA, et al. Perfil de humor de mulheres com fibromialgia. J Bras Psiquiatr. 2011;60(3):216-20. https://doi.org/10.1590/S0047-20852011000300011.
The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403-9. PMID: 8560308; https://doi.org/10.1016/0277-9536(95)00112-K.
Camargo RS, Moser AD, Bastos LC. Abordagem dos métodos avaliativos em fibromialgia e dor crônica aplicada à tecnologia da informação: revisão da literatura em periódicos, entre 1998 e 2008. Rev Bras Reumatol. 2009;49(4):431-46. https://doi.org/10.1590/S0482-50042009000400009.
von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-7. PMID: 18064739; https://doi.org/10.1016/s0140-6736(07)61602-x.
Marques AP, Santos AMB, Assumpção A, et al. Validação da versão brasileira do Fibromyalgia Impact Questionnaire (FIQ). Rev Bras Reumatol. 2006;46(1):24-31. https://doi.org/10.1590/S0482-50042006000100006.
Monterde S, Salvat I, Montull S, Fernández-Ballart J. Validación de la versión española del Fibromyalgia Impact Questionnaire. Rev Esp Reumatol. 2004;31(9):507-13.
Peinado-Rubia A, Osuna-Pérez MC, Rodríguez-Almagro D, et al. Impaired Balance in Patients with Fibromyalgia Syndrome: Predictors of the Impact of This Disorder and Balance Confidence. Int J Environ Res Public Health. 2020;17(9):3160. PMID: 32370043; https://doi.org/10.3390/ijerph17093160.
Martinez JE, Bologna SC, El-Kadre JM. Is there correlation between the degree of resilience and the impact of quality of life in patients with fibromyalgia?. Rev Fac Cienc Med Sorocaba. 2017;19(1):6-9. https://doi.org/10.5327/Z1984-4840201725579.
Martins MR, Polvero LO, Rocha CE, Foss MH, Santos Junior RD. Using questionnaires to assess the quality of life and multidimensionality of fibromyalgia patients. Rev Bras Reumatol. 2012;52(1):21-6. PMID: 22286642.
Lorena SB, Pimentel EAS, Fernandes VM, et al. Avaliação de dor e qualidade de vida de pacientes com fibromialgia. Rev Dor. 2016;17(1):8-11. https://doi.org/10.5935/1806-0013.20160003.
Tangen SF, Helvik AS, Eide H, Fors EA. Pain acceptance and its impact on function and symptoms in fibromyalgia. Scand J Pain. 2020;20(4):727-36. PMID: 32759409.https://doi.org/10.1515/sjpain-2020-0049.
Martins MR, Gritti CC, dos Santos Junior R, et al. Randomized controlled trial of a therapeutic intervention group in patients with fibromyalgia syndrome. Rev Bras Reumatol. 2014;54(3):179-84. PMID: 25054594; https://doi.org/10.1016/j.rbr.2013.10.005.
Berk E, Baykara S. The relationship between disease severity and defense mechanisms in fibromyalgia syndrome. Turk J Phys Med Rehabil. 2020;66(1):47-53. PMID: 32318674; https://doi.org/10.5606/tftrd.2020.3331.
Salaffi F, Giorgi V, Sirotti S, et al. The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome. Clin Exp Rheumatol. 2021;39 Suppl 130(3):72-7. PMID: 33200740; https://doi.org/10.55563/clinexprheumatol/dnxtch.
Cankurtaran D, Tezel N, Ercan B, Yildiz SY, Akyuz EU. The effects of COVID-19 fear and anxiety on symptom severity, sleep quality, and mood in patients with fibromyalgia: a pilot study. Adv Rheumatol. 2021;61(1):41. PMID: 34193303; https://doi.org/10.1186/s42358-021-00200-9.
Hausmann JS, Kennedy K, Simard JF, et al. COVID-19 Global Rheumatology Alliance. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases. Lancet Rheumatol. 2021;3(10):e707-e714. PMID: 34316727; https://doi.org/10.1016/s2665-9913(21)00175-2.
AlEnzi F, Alhamal S, Alramadhan M, et al. Fibromyalgia in Health Care Worker During COVID-19 Outbreak in Saudi Arabia. Front Public Health. 2021;9:693159. PMID: 34568254; https://doi.org/10.3389/fpubh.2021.693159.
Lai J, Ma S, Wang Y, et al. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw Open. 2020;3(3):e203976. PMID: 32202646; https://doi.org/10.1001/jamanetworkopen.2020.3976.
Aloush V, Gurfinkel A, Shachar N, Ablin JN, Elkana O. Physical and mental impact of COVID-19 outbreak on fibromyalgia patients. Clin Exp Rheumatol. 2021;39 Suppl 130(3):108-14. PMID: 33734970; https://doi.org/10.55563/clinexprheumatol/rxk6s4.
Colas C, Jumel A, Vericel MP, et al. Understanding Experiences of Fibromyalgia Patients Involved in the Fimouv Study During COVID-19 Lockdown. Front Psychol. 2021;12:645092. PMID: 34354626; https://doi.org/10.3389/fpsyg.2021.645092.
Koppert TY, Jacobs JWG, Lumley MA, Geenen R. The impact of COVID-19 stress on pain and fatigue in people with and without a central sensitivity syndrome. J Psychosom Res. 2021;151:110655. PMID: 34739944; https://doi.org/10.1016/j.jpsychores.2021.110655.
Martinez JE, Casagrande Pde M, Ferreira PP, Rossatto BL. Correlation between demographic and clinical variables and fibromyalgia severity. Rev Bras Reumatol. 2013;53(6):460-3. PMID: 24477723;https://doi.org/10.1016/j.rbr.2013.04.002.
Laimi K, Mäkilä A, Bärlund E, et al. Effectiveness of myofascial release in treatment of chronic musculoskeletal pain: a systematic review. Clin Rehabil. 2018;32(4):440-50. PMID: 28956477; https://doi.org/10.1177/0269215517732820.
Schulze NB, Salemi MM, de Alencar GG, Moreira MC, de Siqueira GR. Efficacy of Manual Therapy on Pain, Impact of Disease, and Quality of Life in the Treatment of Fibromyalgia: A Systematic Review. Pain Physician. 2020;23(5):461-76. PMID: 32967389.
Stall P, Hosomi JK, Faelli CYP, et al. Effects of structural integration Rolfing® method and acupuncture on fibromyalgia. Rev Dor. 2015;16(2):96-101. https://doi.org/10.5935/1806-0013.20150019.
Perea DCBNM. Fibromialgia: epidemiologia, diagnóstico, fisiopatologia e tratamento fisioterápico. Fisioterapia Brasil. 2003;4(4):282-8. Available from: https://portalatlanticaeditora.com.br/index.php/fisioterapiabrasil/article/view/3039. Accessed in 2022 (Jun 3).
Breda CA, Rodacki AL, Leite N, et al. Physical activity level and physical performance in the 6-minute walk test in women with fibromyalgia. Rev Bras Reumatol. 2013;53(3):276-81. PMID: 24051910; https://doi.org/10.1590/S0482-50042013000300005.
Marques AP, Matsutani AL, Ferreira EAG, Mendonça LLF. A fisioterapia no tratamento de pacientes com fibromialgia: uma revisão da literatura. Rev Bras Reumatol. 2002;42(1):42-8.
Steffens RAK, Liz CM, Viana MS, Brandt R, Oliveira LGA. Praticar caminhada melhora a qualidade do sono e os estados de humor em mulheres com síndrome da fibromialgia. Rev Dor. 2011;12(4):327-31. https://doi.org/10.1590/S1806-00132011000400008.
Andrade A, Dominski FH, Sieczkowska SM. What we already know about the effects of exercise in patients with fibromyalgia: An umbrella review. Semin Arthritis Rheum. 2020;50(6):1465-80. PMID: 32147091; https://doi.org/10.1016/j.semarthrit.2020.02.003.
Atzeni F, Talotta R, Masala IF. One year in review 2019: fibromyalgia. Clin Exp Rheumatol. 2019;37 Suppl 116(1):3-10. PMID: 30747097.
